Endometrial cancer

P Morice, A Leary, C Creutzberg, N Abu-Rustum… - The Lancet, 2016 - thelancet.com
Endometrial cancer is the most common gynaecological tumour in developed countries, and
its incidence is increasing. The most frequently occurring histological subtype is …

Progesterone actions and resistance in gynecological disorders

JA MacLean, K Hayashi - Cells, 2022 - mdpi.com
Estrogen and progesterone and their signaling mechanisms are tightly regulated to maintain
a normal menstrual cycle and to support a successful pregnancy. The imbalance of estrogen …

Endometrial hyperplasia as a risk factor of endometrial cancer

LK Nees, S Heublein, S Steinmacher… - Archives of gynecology …, 2022 - Springer
Endometrial hyperplasia (EH) is the precursor lesion for endometrioid adenocarcinoma of
the endometrium (EC), which represents the most common malignancy of the female …

New concepts for an old problem: the diagnosis of endometrial hyperplasia

PA Sanderson, HOD Critchley… - Human reproduction …, 2017 - academic.oup.com
BACKGROUND Endometrial hyperplasia (EH) is a uterine pathology representing a
spectrum of morphological endometrial alterations. It is predominantly characterized by an …

[PDF][PDF] ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma,

A Rodolakis, G Scambia, F Planchamp… - Human …, 2023 - academic.oup.com
STUDY QUESTION How should fertility-sparing treatment of patients with endometrial
carcinoma be performed? SUMMARY ANSWER Forty-eight recommendations were …

Endometrial cancer

JI Sorosky - Obstetrics & Gynecology, 2012 - journals.lww.com
The epidemiology, prevention, diagnosis, treatment, prognosis, and new International
Federation of Gynecology and Obstetrics staging system of endometrial carcinoma are …

British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice

J Morrison, J Balega, L Buckley, A Clamp… - European Journal of …, 2022 - Elsevier
The remit of this guideline is to collate and propose evidence-based guidelines for the
diagnosis and management of uterine cancer. This document covers all uterine cancers of …

Endometrial hyperplasia

KL Ring, AM Mills, SC Modesitt - Obstetrics & Gynecology, 2022 - journals.lww.com
The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the
etiology and risk factors, histologic classification and subtypes, malignant progression risks …

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review

CC Gunderson, AN Fader, KA Carson, RE Bristow - Gynecologic oncology, 2012 - Elsevier
OBJECTIVE: The objective of this review was to analyze published contemporary oncologic
and reproductive outcomes in women with endometrial hyperplasia or cancer undergoing …

Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis

MT Doherty, OB Sanni, HG Coleman, CR Cardwell… - PloS one, 2020 - journals.plos.org
Background To inform treatment decisions in women diagnosed with endometrial
hyperplasia, quantification of the potential for concurrent endometrial cancer and the future …